Latest News and Press Releases

PRESS RELEASE Arcadis 2025 Extraordinary General Meeting Arcadis’ shareholders appoint Robert Swaak to the Supervisory Board Amsterdam, 10 July 2025 – Arcadis (EURONEXT: ARCAD), the world’s...

NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Bastion, a pioneer in regulated digital asset and stablecoin infrastructure and NYDFS chartered provider, today announced the appointment of Jared Klee as...

TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Copper Road Resources Inc. (TSX-V: CRD) ("Copper Road" or the "Company") announces the appointment of Mr. Brian Howlett as President and CEO, effectively...

TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQB: BMOOF), is pleased to announce the selection of Worley Limited (“Worley”), a...

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 July 2025 – Essential Pharma (“Essential” or “the Company”), a global...

Zapp EV Reports Financial Results for the Six Months Ended March 31, 2025 and Provides Operational Update

Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director Egham, UK – 25 June 2025 – Essential Pharma (“Essential” or “the Company”), a global...

Anchorage Alaska, June 24, 2025 (GLOBE NEWSWIRE) -- Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) ) is pleased to announce that Mr. Chaim (Dovi) Berger has been...

Basel, Switzerland – June 18, 2025 - TOLREMO therapeutics AG (TOLREMO), a clinical-stage biotechnology company developing TT125-802, a best-in-class CBP/p300 bromodomain inhibitor for the treatment of...

Cambridge, UK, 17 June 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G protein coupled receptor (GPCR)-driven diseases,...